⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3439225 | 0.55 | — | — | |
| SCHEMBL10426602 | 0.53 | — | — | |
| SCHEMBL1431864 | 0.53 | — | — | |
| SCHEMBL232122 | 0.53 | — | — | |
| SCHEMBL3572806 | 0.52 | — | — | |
| SCHEMBL119955 | 0.46 | — | — | |
| SCHEMBL7981543 | 0.46 | — | — | |
| SCHEMBL7645220 | 0.43 | TRIM24 (0.64) | — | |
| SCHEMBL3115436 | 0.43 | — | — | |
| SCHEMBL3118747 | 0.43 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2970146-B1 | ACYLAMINOCYCLOALKYL COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF DOPAMINE D3 RECEPTOR | ABBVIE DEUTSCHLAND (DE) | 2017-11-01 | — | — | EP | claimed |
| EP-2252612-B1 | HETEROCYCLIC COMPOUNDS AND COMPOSITIONS AS C-KIT AND PDGFR KINASE INHIBITORS | IRM LLC (BM) | 2012-03-28 | — | — | EP | claimed |
| EP-1761542-B1 | OCTAHYDROPYRROLO[3,4-C]PYRROLE DERIVATIVES AN THEIR USE AS ANTIVIRAL AGENTS | HOFFMANN LA ROCHE (CH) | 2008-01-02 | — | — | EP | claimed |
| EP-0793499-B1 | METHOD AND COMPOSITION FOR REDUCING TUMOR DEVELOPMENT WITH A COMBINATION OF A TAXANE COMPOUND AND A TELLURIUM AND/OR SELENIUM COMPOUND | BAKER NORTON PHARMA (US) | 2005-10-19 | — | — | EP | claimed |